Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Foresite Capital Management V, LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
07/19/2023 4 Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.
Txns: Bought 523,450 shares @ $2.97, valued at $1.6M
Bought 176,550 shares @ $2.97, valued at $524.4k
05/12/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/10/2023 4 Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Bought 1,550,956 shares @ $2.8, valued at $4.3M
Bought 229,044 shares @ $2.8, valued at $641.3k
02/22/2023 4 Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Acquired 1,100,000 shares @ $0
02/13/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
01/03/2023 4 Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.
Txns: Bought 250,000 shares @ $5, valued at $1.3M
Bought 250,000 shares @ $5, valued at $1.3M
12/05/2022 4 Foresite Capital Management V, LLC (10% Owner) has filed a Form 4 on PARDES BIOSCIENCES, INC.
Txns: Bought 637,420 shares @ $0.85, valued at $541.8k
06/13/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/10/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
05/13/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/11/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
12/30/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
12/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/03/2021 4 Foresite Capital Management III, LLC (10% Owner) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Disposed of 1,954,904 shares @ $0
Acquired 8,276 shares @ $0
08/13/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/14/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/23/2021 4 FS Development Holdings II, LLC (10% Owner) has filed a Form 4 on FS Development Corp. II
Txns: Bought 602,500 shares @ $10, valued at $6M
02/16/2021 3 FS Development Holdings II, LLC (10% Owner) has filed a Form 3 on FS Development Corp. II
02/16/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/09/2021 4 FS Development Holdings, LLC (10% Owner) has filed a Form 4 on Gemini Therapeutics, Inc. /DE
Txns: Granted 1,500,000 shares @ $10, valued at $15M
Converted 2,928,750 shares @ $0
Converted 2,928,750 options to buy @ $0
12/09/2020 4 Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Converted 9,171,643 shares @ $0
Converted 500,001 shares @ $0
Converted 166,667 shares @ $0
Converted 6,347,893 preferred shares @ $0
Converted 298,465 preferred shares @ $0
Converted 99,488 preferred shares @ $0
Converted 2,666,002 preferred shares @ $0
Converted 55,922 preferred shares @ $0
Converted 18,641 preferred shares @ $0
Converted 157,222 preferred shares @ $0
Converted 145,128 preferred shares @ $0
12/04/2020 4 Foresite Capital Management IV, LLC (10% Owner) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 500,000 shares @ $20, valued at $10M
Granted 375,000 shares @ $20, valued at $7.5M
Granted 125,000 shares @ $20, valued at $2.5M
12/03/2020 3 Foresite Capital Management IV, LLC (10% Owner) has filed a Form 3 on Kinnate Biopharma Inc.
10/19/2020 4 FS Development Holdings, LLC (10% Owner) has filed a Form 4 on FS Development Corp.
Txns: Bought 441,500 shares @ $10, valued at $4.4M
08/19/2020 3/A FS Development Holdings, LLC (10% Owner) has filed a Form 3/A on FS Development Corp.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy